25
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Short Communication: The effect of CYP1A1 induction on the formation of benzo a pyrene adducts in liver and lung DNA and plasma albumin in rats exposed to benzo a pyrene:adduct quantitation by immunoassay and an HPLC method

Pages 37-47 | Published online: 29 Sep 2008

Reference

  • ALEXANDROV, K., ROJAS, M., GENESTE, O., CASTEGNARO, M., CAMUS, A. M., PETRUZZELLI, S., GIUNTINI, C. and BARTSC HH. 1992, An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparison with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Research, 52, 6248–6253.
  • ARIF, J. M. and GUPTA, R. C. 1996, Detection of DNA-reactive metabolites in serum and their tissue distribution in mice exposed to multiple doses of carcinogen mixtures: role in human biomonitoring. Carcinogen esis, 17, 2213–2219.
  • BEACH, A. C. and GUPTA, R. C. 1992, Human biomonitoring and the 32P-postlabelling assay. Carcinogenesis, 13, 1053–1074.
  • BJELOGRLIC, N., PENG, R., PARK, S. S., GELBOIN, H. V., HONKAKOSKI, P., PELKONEN, O. and VAHAKANGAs, K. 1993, Involvement of P-450 1A1 in benzo[a]pyrene but not in benzo [a]pyrene-7,8- dihydrodiol activation by 3 -methylcholanthrene-induced mouse liver microsomes. Pharmacology & Toxicology, 73,319–324.
  • DAY, B. W., SKIPPER, P. L., ZAIA, J., SINGH, K. and TANNENBAUM, S. R. 1994, Enantiospecificity of covalent adduct formation by benzo[a]pyrene anti-diol epoxide with human serum albumin. Chemical Research in Toxicology, 7, 829–835.
  • DIPPLE, A. and BIGGER, C. Anita H. 1991, Mechanism of action of food-associated polycyclic aromatic hydrocarbon carcinogens. Mutation Research, 259, 263–276.
  • DIPPLE, A., MOSCHEL, R. C. and BIGGER, C. A. H. 1984, Polynuclear aromatic carcinogens. In Chemical Carcinogens, C. E. Searle, ed. (Washington, DC: American Chemical Society), pp. 41–163.
  • GAMMAGE, R. B. 1983, Polycyclic aromatic hydrocarbons in work atmospheres. In Handbook of Polycydic Aromatic Hydrocarbons A. Bjorseth, ed. (Marcel Dekker, Inc.: New York), pp. 653–707.
  • GELBOIN, H. V. 1980, Benz° [a] pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiological Reviews, 60, 1107–1166.
  • GODSCHALK, R. W. L., Vermeer, I. T. M., KRIEK, E., FLOOT, B., SCHILDERMAN, P. A. E. L., MOONEN, E. J. C., KLEINJANS, J. C. S. and VAN SCHOOTEN, E -J. 1997, Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene. Chemico-Biological Interactions, 104, 41–54.
  • HALL, M. and GROVER, P. L. 1990, Polycyclic aromatic hydrocarbons: Metabolism, activation and tumor initiation. In Handbook of Experimental Pharmacology, Chemical Carcfriogenesis and Mutagenesis, Vol 94/11, C. S. Cooper and P. L. Grover, eds (Berlin: Springer Verlag), pp. 327–372.
  • HARVEY, R. G. 1980, Carcinogenic hydrocarbons: metabolic activation and the mechanism of cancer induction. In Safe Handling of Chemical Carcinogens, Mutagen..s Teratogens and Highly Toxic Substances, D. B. Walters, ed. (MI: Ann Arbor Science Publishers), pp. 439–468.
  • HEMMINKI, K. 1995, DNA adducts in biomonitoring. Occupational and Environmental Medicine, 37,44-51. HESSE, S., JERNSTROM, B., MARTINEZ, M., MOLDFUS, P., CHRISTODOULIDES, L. and KETTERER, B. 1982, Inactivation of DNA-binding metabolites of benzo[a]pyrene and benzo[a]pyrene-7,8- dihydrodiol by glutathione and glutathione S-transferases. Carcino genesis, 3,757–760.
  • HUGHES, N. C. and PHILLIPS, D. H. 1990, Covalent binding of dibenzpyrenes and benzo[a]pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Carcino genesis, 11, 1611–1619.
  • IARC 1983a, M cnographs on the evaluation of the carcinogenic risk of chemicals to humans. Polynuclear aromatic compounds. Chemical, environmental and experimental data, Vol. 32 (Lyon: International Agency for Research on Cancer).
  • IARC 1983b, Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Polynuclear aromatic compounds. Industrial exposures in aluminium production, coal gasification, coke production, and iron and steel founding, Vol. 34, part 3 (Lyon: International Agency for Research on Cancer).
  • JONES, C. A., SANTELLA, R. M., HUBERMAN, E., SELKIRK, J. K. and GRUNBERGER, D. 1983, Cell specific activation of benzo[a]pyrene by fibroblasts and hepatocytes. Carcinogenesis 4, 1351–1357.
  • LABARCA, C. and PAIGEN, K. 1980, A simple, rapid, and sensitive DNA assay procedure. Analytical Biochemistry, 102,344–352.
  • LAKE, B. G. 1987, Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In Biochemical Toxicology: a Practical Approach, K. Snell and B. Mullock, eds, (Oxford IRL Press), pp. 183–215.
  • LOWRY, O. H., ROSEBROUGH, N. J., FM, A. L. and RANDALL, R. J. 1951, Protein measurement with the Folin Phenol Reagent. Journal of Biological Chemistry, 193,265–275.
  • MACKAY, W., BENASUTTI, M., DROUIN, E. and LOECHLER, E. L. 1992, Mutagenesis by (+)-anti-B[a]P - N2 -Gua, the major adduct of activated benzo[a]pyrene, when studied in an Escherichia coli plasmid using site-directed methods. Carcinogenesis 13, 1415–1425.
  • MEYER, M. J. and BECHTOLD, W. E. 1996, Protein adduct biomarkers: state of the art. Environmental Health Perspectives, 104, 879–881.
  • NEBERT, D. W. 1989, The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Critical Reviews in Toxicology, 20, 153–174.
  • NEBERT, D. W., PETERSEN, D. D. and FORNACE, JR, A. J. 1990, Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. Environmental Health Perspectives, 88,13–25.
  • NEWMAN, M. J., LIGHT, B. A., WESTON, A., TOLLERUD, D., CLARK, J. L., MANN D. L., BLACKMON, J. P. and HARRIS C. C. 1988, Detection and characterization of human serum antibodies to polycyclic aromatic hydrocarbon diol-epoxide DNA adducts. Journal of Clinical Investigation, 82, 145–153.
  • OLSEN, J. H., WALLIN, H., BOICE, J. D. J., RASK, K., SCHULGEN, G. and FRAUMENI, J. E J. 1993, Phenobarbital, drug metabolism, and human cancer. Cancer Epidemiology Biomarkers & Prevention, 2, 449–452.
  • OVREBO, S., HAUGEN, A., PHILLIPS, D. H. and HEWER, A. 1992, Detection of polycyclic aromatic hydrocarbon—DNA adducts in white blood cells from coke oven workers: correlation with job categories. Cancer Research, 52, 1510–1514.
  • QU, S. X. and STACEY, N. H. 1996, Formation and persistence of DNA adducts in different target tissues of rats after multiple administration of benzo[a]pyrene. Carcinogenesi,s17, 53–59.
  • RAHN, R. O., CHANG, S. S., HOLLAND, J. M. and SHUGART, L. R. 1982, A fluorometric-HPLC assay for quantitating the binding of benzo[a]pyrene metabolites to DNA. Biochemical and Biophysical Research Communication, 109, 262–268.
  • RODRIGUES, A. D. and PROUGH, R. A. 1991, Induction of cytochromes P4501A1 and P450IA2 and measurement of catalytic activities. In Methods in Enzymology, Vol. 206, S. P. Colowick and N. O. Kaplan, eds (Academic Press, Inc: San Diego), pp. 423–431.
  • ROGGEBAND, R., WOLTERBEEK, A. P., RUTTEN, A. A. and BAN, R. A. 1993, Comparative 32P - postlabelling analysis of benzo[a]pyrene—DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes. Carcinogenesis, 14, 1945–1950.
  • ROJAS, M., ALEXANDROV, K., VAN SCHOOTEN, E-J., HILLEBRAND, M., KRIEK, E. and BARTSCH, H. 1994, Validation of a new fluorometric assay for benzo[a]pyrene diolepoxide—DNA adducts in human white blood cells: comparisons with 32P-postlabelling and ELISA. Carcino genesis, 15, 557–560.
  • ROSS, J., NELSON, G., KLIGERMAN, A., EREXSON, G., BRYANT, M., EARLEY, K., GUPTA R. and NESNOW, S. 1990, Formation and persistence of novel benzo[a]pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA. Cancer Research, 50,5088–5094
  • ROSS, J., NELSON, G., EREXSON, G., KLIGERMAN, A., EARLEY, K., GUPTA, R. C. and NESNOW, S. 1991, DNA adducts in rat lung, liver and peripheral blood lymphocytes produced by i.p. administration of benzo[a]pyrene metabolites and derivatives. Carcinogenesis 12, 1953–1955.
  • SANTELLA, R. M., WESTON, A., PERERA, E P., TRIVERS, G. T., HARRIS, C. C., YOUNG T. L., NGUYEN, D., LEE, B. M. and POIRIER, M. C. 1988, Interlaboratory comparison of antisera and immunoassays for benzo [a] pyrene-diol-epoxide-I-modified DNA. Carcino genesis, 9, 1265–1269.
  • SKIPPER, P. L., GREEN, L. C., BRYANT, M. S. and TANNENBAUM, S. R. 1984, Monitoring exposure to 4-aminobiphenyl via blood protein adducts. In Monitoring human exposure to carcinogenic and mutagenic agents, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans Vol. 59 (Lyon: International Agency for Research on Cancer), pp. 143–150.
  • STOWERS, J. and ANDERSON, M. W. 1985, Formation and persistence of benzo[a]pyrene metabolite—DNA adducts. Environmental Health Perspectives, 62, 31–39.
  • WALL, K. L., WENSHI, G., KOPPELE, J. M., KWEI, G. Y., KAUFFMAN, F. C. and THURMAN, R. G. 1991, The liver plays a central role in the mechanism of chemical carcinogenesis due to polycyclic aromatic hydrocarbons. Carcinogenesis 12, 783–786.
  • WEYAND, E. H., CHEN, Y. C., Wu, Y., KOGANTI, A., DUNSFORD, H. A. and RODRIGUEZ, L. V. 1995, Differences in the tumorigenic activity of a pure hydrocarbon and a complex mixture following ingestion: benzo[alpha]pyrene vs manufactured gas plant residue. Chemical Research in Toxicology, 8, 949–954.
  • YANG, S. K., SELKIRK, J. K., PLOTKIN, E. V. and GELBOIN, H. V. 1997, Kinetic analysis of the metabolism of benzo[a]pyrene to phenols, dihydrodiols, and quinones by high-pressure chromatography compared with analysis by aryl hydrocarbon hydroxylase assay, and the effect of enzyme induction. Cancer Research, 35, 3642–3650.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.